Education
About Us
Working with TipRanks
Follow Us
CAMP4 Therapeutics Corporation (CAMP)
NASDAQ:CAMP
RESEARCH TOOLSreports
| Dec 24 | Mar 23 | Mar 22 | Mar 21 | Mar 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 652.00K | $ 294.95M | $ 295.84M | $ 308.59M | $ 366.11M |
| Gross Profit | $ 652.00K | $ 109.01M | $ 121.89M | $ 122.41M | $ 143.30M |
| Operating Income | $ -53.09M | $ -21.48M | $ -15.31M | $ -3.87M | $ -16.77M |
| EBITDA | $ -51.39M | $ 276.00K | $ 7.49M | $ 18.13M | $ 15.22M |
| Net Income | $ -51.79M | $ -32.49M | $ -31.15M | $ -21.16M | $ -78.77M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 64.04M | $ 41.93M | $ 79.22M | $ 94.62M | $ 107.40M |
| Total Assets | $ 78.31M | $ 380.12M | $ 391.58M | $ 433.81M | $ 495.81M |
| Total Debt | $ 8.65M | $ 240.44M | $ 205.67M | $ 203.53M | $ 234.49M |
| Net Debt | $ -55.39M | $ 198.51M | $ 126.45M | $ 108.91M | $ 127.08M |
| Total Liabilities | $ 15.16M | $ 365.81M | $ 316.18M | $ 338.72M | $ 357.89M |
| Stockholders' Equity | $ 63.14M | $ 14.31M | $ 75.40M | $ 95.08M | $ 137.92M |
| Cash Flow | |||||
| Free Cash Flow | $ -46.00M | $ -42.57M | $ -17.52M | $ 17.23M | $ -9.76M |
| Operating Cash Flow | $ -45.56M | $ -38.54M | $ -4.22M | $ 28.59M | $ 11.54M |
| Investing Cash Flow | $ -441.00K | $ -4.03M | $ -7.58M | $ -13.69M | $ -65.70M |
| Financing Cash Flow | $ 71.66M | $ 100.16M | $ -2.64M | $ -27.32M | $ -94.82M |